Compare ATEN & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATEN | BLFS |
|---|---|---|
| Founded | 2004 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2014 | 1989 |
| Metric | ATEN | BLFS |
|---|---|---|
| Price | $20.60 | $22.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $22.67 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 921.6K | 362.4K |
| Earning Date | 02-04-2026 | 03-02-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $290,557,000.00 | $100,144,000.00 |
| Revenue This Year | $9.40 | $18.45 |
| Revenue Next Year | $7.65 | $16.27 |
| P/E Ratio | $36.32 | ★ N/A |
| Revenue Growth | 11.03 | ★ 87.53 |
| 52 Week Low | $13.81 | $19.10 |
| 52 Week High | $21.90 | $29.62 |
| Indicator | ATEN | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 40.63 |
| Support Level | $20.17 | $21.45 |
| Resistance Level | $21.31 | $22.99 |
| Average True Range (ATR) | 0.78 | 1.09 |
| MACD | 0.29 | -0.07 |
| Stochastic Oscillator | 79.60 | 21.19 |
A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.